COSA 2015* , ,
Presentations this author is a contributor to:
Phase 3, randomized trial (CheckMate 017) of nivolumab (Nivo) vs docetaxel in advanced squamous (SQ) cell non-small cell lung cancer (NSCLC) (#214)
3:00 PM
Karen Reckamp
Posters1
Longer-term follow-up of a phase 2 study (CheckMate 063) of nivolumab in patients with advanced refractory squamous (SQ) non-small cell lung cancer (NSCLC) (#200)
3:00 PM
Leora Horn
Posters1